Horizon Pharma to acquire Raptor Pharmaceutical for $800M: 5 things to know

Lake Forest, Ill.-based Horizon Pharma will reportedly buy La Jolla, Calif.-based Raptor Pharmaceutical for $800 million, according to Reuters.

Advertisement

Here are five things to know about the Horizon, Raptor deal:

1. Horizon said it would pay $9 for each Raptor share, which were trading at $8.96 at the time of the statement.

2. Horizon CEO Tim Walbert has been vocal about his intention to expand the company through acquisitions.

3. According to Reuters, Mr. Walbert said he wants to heighten Horizon’s focus on rare diseases, shifting the company away from primary care where pricing pressure has been more prominent.

4. In 2015, Raptor generated $94.2 million in revenue and expects to hit $125 to $135 in 2016.

5. Horizon will reportedly finance the Raptor transaction via $675 million of external debt along with cash on hand. Horizon expects the deal to close in the fourth quarter, according to Reuters.

More articles on supply chain: 
St. Louis-based medical device startup nets $25M to expand product line 
Glenmark receives FDA approval for lidocaine ointment 
FDA approves Obalon Balloon System as weight loss aid

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Supply Chain

  • Aurora, Colo.-based UCHealth Vice President of Supply Chain Richard Bagley has retired after more than four years with the health…

  • The FDA has flagged eight medical device recalls, corrections and early alerts affecting convenience kits, vascular access devices, IV administration…

Advertisement

Comments are closed.